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During recent years, minimally invasive surgery (MIS) has become the standard approach
for various operations in infants and children. This also holds true for surgery in children
with solid tumors. Meanwhile, more and more oncological biopsies and resections are
being performed laparoscopically or thoracoscopically. Despite its increasing role in pedi-
atric tumor surgery, the different national and international multicenter trial groups have
not yet implemented MIS within guidelines and recommendations in most of the current
treatment protocols. An increasing number of reports describe a potential role of MIS in
the different entities of pediatric surgical oncology. Over the time, there has been a diverse
development of this approach with regard to the different neoplasms.The aim of this article
is to give an overview and to describe the current state of the art of MIS in pediatric solid
tumors.
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GENERAL CONSIDERATIONS
The outcome of children suffering from solid tumors has been
dramatically improved over the past 30 years. Several reasons are
responsible for this fact. One major factor in this regard is the
treatment of patients according to guidelines and protocols estab-
lished by multicenter trial groups. With great efforts, the different
groups have realized a constant development and improvement
of treatment modalities for every entity. Today, the most relevant
groups with the largest experiences are the International Soci-
ety of Pediatric Oncology (SIOP) in Europe and overseas, the
Children’s Oncology Group (COG) in the US and North Amer-
ica, the Society of Pediatric Oncology and Hematology (GPOH)
in Germany, Austria, and Switzerland, and the Japanese Pedi-
atric Liver Tumor Study Group (JPLT) in Japan. A common
perception of these groups is the continuing improvement of
patient outcomes through combined therapy approaches integrat-
ing chemotherapy, surgery, and/or radiotherapy into concerted
treatment concepts (1).
Besides these combined approaches, there has been a relevant
advancement and improvement of every single portion of the dif-
ferent treatment aspects. For the surgical field, there are numerous
examples for such advancements.
Minimally invasive surgery (MIS) has become the standard
treatment approach for many operations within all age groups in
pediatric surgery (2–5). From an early phase of this development
on, oncological surgical procedures were performed minimal-
invasively in children. Early reports described several limitations
of the method because of various reasons (6–8). With an increase
of frequencies, there was a growing knowledge on MIS in children
with solid tumors. Nevertheless, several relevant issues and lim-
itations have constantly been discussed, which make a general
judgment of the method difficult.
The characteristics of the different frequent pediatric solid
tumors are largely varying. This especially concerns tumor biol-
ogy, affected organs, growth pattern, treatment concepts, and other
factors. The heterogeneity of the different entities requires differ-
ing treatment concepts; accordingly, the role of surgery differs to
a large degree from entity to entity. Tumor biopsy represents an
example in this regard. In some tumors, a biopsy is required; some-
times biopsy is allowed but not mandatory, and sometimes it must
not be performed. Some children with tumors receive neoadjuvant
chemotherapy; some patients undergo upfront tumor resection.
In some tumors, complete microscopic resection is of prognos-
tic significance, in some tumors minimal residual disease can be
accepted. Because of this differing role of surgery in the different
entities, it is not possible to attribute a common objective to a
single surgical approach such as MIS.
Reports of minimally invasive surgical procedures are increas-
ingly observable. In a relevant number of cases, pediatric surgeons
with a main focus of their work being MIS and not oncological
surgery are performing these procedures. However, the emphasis
of surgery in children with solid tumors lies not on the feasibility
but on the strict adherence to oncological principles. It has there-
fore been repeatedly postulated that surgeons performing MIS for
solid tumors in children should have experience in both fields, MIS
and oncological surgery. This aspect is even more relevant since
guidelines within the current treatment protocols of multi cen-
ter trials are regularly lacking recommendations on MIS. These
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guidelines were often established some years ago when MIS did
not play a prominent role in the surgical treatment of children
with solid tumors (9, 10). Also, no randomized controlled trials or
controlled clinical trials have been conducted so far analyzing sur-
gical and oncological outcomes of MIS in pediatric tumor patients
compared to open surgery (11). Several study protocols are cur-
rently in the process of being renewed. Therefore, it is a central
task to surgeons involved in these proceedings to establish guide-
lines for MIS in children suffering from respective neoplasms to
be implemented in the treatment protocols by the steering groups.
Despite all efforts of engaged surgeons to assess the role of MIS
in pediatric surgical oncology and to have patients benefit from its
advances, there are still relevant limitations of the approach. Some
disadvantages of MIS are known from other surgical fields such
as the tactile deficit and the limited visualization of lesions, which
are not located on an organ surface. However, there are additional
constraints that are especially relevant for oncological operations.
It is a known fact that the radiological findings before surgery
do not always correspond well with the intraoperative aspects.
For example, in surgery for lung metastases, imaging possibly
underestimates the number of pulmonary nodules to a relevant
degree (12, 13). Also, it can be difficult in some cases to estimate
the delineation of borders between tumor and unaffected tissue
and thus to distinguish between infiltration and displacement of
organs. A potential consequence during surgery is to leave tumor
behind or to damage healthy organs with an increased risk for
organ dysfunction or other co-morbidities. Under such circum-
stances, conversion to the open approach should not be judged as
complication but rather as thoughtful course of action. Operat-
ing surgeons should always keep the safety of the patients and the
correctness of the operations in mind.
In the following, the current state of the art regarding MIS
in children with solid tumors will be displayed focusing on the
entities within the thorax or abdomen, that are most commonly
operated using MIS as approach.
THORACIC TUMORS
Primary thoracic tumors are usually surgically classified accord-
ing to their anatomical occurrence. Most common tumors of the
anterior mediastinum are lymphoma, thymus processes, angioma,
lymphangioma, sarcoma, and germ cell tumors. Most com-
mon neoplasms of the middle mediastinum are lymphoma and
angioma and most common tumors of the posterior mediastinum
are neurogenic tumors and sarcoma (14). MIS is most relevant
for biopsy in these tumors. Thoracoscopic resections are mostly
carried out in lesions of the posterior mediastinum (14–17).
Technical challenges of MIS for thoracic tumors are relevant.
The use of single lung ventilation is generally recommended, how-
ever, it can be difficult to establish in small children and infants.
Handling and removal of the resected specimen from the thoracic
cavity should be performed using a retrieval bag; in some cases, a
mini-thoracotomy might become necessary for this purpose.
In small children, MIS for thoracic pathologies is possibly
limited because of a small working space. Also, mechanical ven-
tilation during surgery can be relevantly hampered because of
lung compression and increased intra-thoracic pressure. Finally,
the intraoperative carbon dioxide uptake might represent an
anesthesiological issue that needs further evaluation.
THORACIC NEUROGENIC TUMORS
Minimally invasive surgery for resection of primary thoracic
tumors is most often executed for neurogenic tumors. These
tumors usually arise along the vertebral column within the poste-
rior mediastinum and often show a benign or moderately aggres-
sive biological behavior (14). The group of thoracic neurogenic
tumors in children includes neuroblastoma, ganglioneuroma,
Schwannoma, neurofibroma, and ganglioneuroma. They regularly
appear quite specific on imaging. MIS has become a commonly
used approach in these cases for biopsy and resection. Several
studies could demonstrate equally good oncological and surgical
outcomes in respective patients compared to open surgery (18–
21). Surgical and clinical outcomes seem superior in comparison
to the open approach because patients are spared thoracotomies or
sternotomies. Long-term survival of children undergoing thoraco-
scopic resection of mediastinal neurogenic tumors seems higher
when compared with those reported for other primary neuro-
genic tumor localizations (20, 21). However, extensive resection
with relevant risk of functional damage should not be performed
in benign cases, irrespective of the treatment approach (14).
THORACIC TERATOMA
Approximately 4% of all germ cell tumors are located within the
thorax, especially within the anterior mediastinum (22). Benign
differentiated teratomas are usually well-confined and consist of
components of all three germinal layers.
The well-known tumor markers AFP and beta-HCG are indi-
cators for malignant components within the tumors (yolk-sac
or chorio-carcinoma). Complete surgical resection represents the
most important prognostic factor for patients with malignant
germ cell tumors of the thorax. Moreover,malignant thoracic germ
cell tumors often present with a local stage T2 because of infiltra-
tion of the surrounding tissue (22). For these reasons, the use of
MIS for resection has to be judged critically within this group.
PULMONARY METASTASES
Thoracoscopy has been suggested for approaching various con-
ditions of lung metastases from solid tumors in children (16,
23–25). General recommendations proposed MIS as preferable
tool for biopsy of lung nodules if tissue for biological information
is needed without intention to completely remove all lesions visible
on diagnostic imaging (23). Regularly, there is a relevant discrep-
ancy between the number of radiologically detectable lung nod-
ules and the respective intraoperative findings. This discrepancy
becomes more and more relevant with the increase of lung nodule
numbers (12, 13). Important limitations have to be taken into con-
sideration with regard to MIS for lung metastases. This especially
concerns the lack of tactile abilities and the inability to intraop-
eratively visualize lesions that are deeper within the parenchyma.
Different tools have been suggested in order to improve the intra-
operative detection during MIS of lung metastases that are not
visible on the lung surface. These approaches include preopera-
tive labeling (coils, coil wires, color dye, or radionuclides) as well
as minimally invasive thoracoscopic ultrasound (26–29). Together
with constantly improved diagnostic procedures, these tools make
pulmonary metastases becoming more and more susceptible to
MIS. However, in some conditions the completeness of pulmonary
metastasis resection is associated with a high prognostic impact,
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as it has been demonstrated for nephroblastoma (30). As con-
sequence, the use of MIS for resection of pulmonary metastases
should only be performed according to respective treatment guide-
lines within the trial protocols and considering the biological
background of the tumors.
ABDOMINAL TUMORS
Laparoscopy is regularly performed for various conditions of
abdominal solid malignancies in children. Early reports have
attempted to define the role of MIS in this group. Up to date,
there is no definite consensus although most authors distinguish
between a relevant role of MIS for biopsies as well as a limited
role for tumor resections (8, 31). Main advantages of MIS seem
to be a reduced time to postoperative mobilization and feeding as
well as reduced time to a subsequent chemotherapy. Some authors
reported on complex minimally invasive procedures for resection
of malignancies in adults and in children. Examples such as laparo-
scopic anatomical liver resections or complex procedures on the
pancreas and biliary tract in adults are indicating that there still is
an ongoing development in that specific field (32–34).
The impact of MIS on tumor growth or biology has been an ele-
ment of discussion for a while delivering inconsistent observations
in preclinical models. This especially concerns the use of carbon
dioxide (35, 36). However, after being used for a relevant time
with respective follow-up, clinical experiences with laparoscopy
for pediatric abdominal malignancies seem to indicate that there
are no relevant differences in outcome compared to open surgical
procedures. However, principles of oncological surgery have to be
strictly respected using MIS. Especially because of a broad variety
of characteristics from entity to entity there is still an ongoing need
for a definite evaluation of MIS in affected children.
The modality of tumor removal from the abdominal cavity
is varying relevantly between different surgeons and obviously
depends on several factors such as tumor size and volume in rela-
tion to the patient, tumor histology, and patients’ conditions. The
use of a retrieval bag often in combination with a small laparotomy
(mostly Pfannenstiel incision) is regularly carried out. Port-site
metastases seem to be rather rare events if enough caution is given
to the handling of the tumors (37, 38).
ADRENAL TUMORS
Abdominal adrenal tumors display a wide variance of his-
tological, biological, and anatomical features. Most common
pathologies include neuroblastoma, ganglioneuroma, adenoma,
and pheochromocytoma (39).
Adrenal neurogenic tumors are regularly well-confined and not
infiltrating or encasing substantial organs and structures. In such
cases, MIS for biopsy and/or resection has been established as
safe alternative to open surgery, especially if the tumor size is not
excelling a certain limit (40–42). However, a complex spatial rela-
tionship to vital structures is possible and represents a relevant
obstacle for MIS.
Neuroblastomas in small infants do often not seem to need sur-
gical treatment. In such cases, even if they appear resectable with-
out great efforts, surgery contains an additional risk for morbidity.
The proposed primary approach in this subgroup of patients is
expectant observation. Secondary surgery becomes necessary in
this setting in case of a 50% increase in the volume of the mass,
urine catecholamine values, or an increase in the homovanillic acid
to vanillylmandelic acid ratio >2. Even MIS seems not to be justi-
fied as primary approach in these selected cases because event-free
survival and overall survival is excellent when patients undergo the
cited approach of expectant observation as primary therapy (43).
Adrenocortical carcinoma has an exceptional position within
the group of adrenal tumors. They are associated with relevantly
inferior oncological outcomes after MIS because of a higher rate of
relapses after resection. Although feasible and tempting in many
cases, laparoscopic biopsy or resection should not be attempted
in patients with tumors suspicious for or known to be adreno-
cortical carcinoma (44, 45). Often, it is possible to distinguish
adrenocortical carcinomas from other adrenal tumors because of
their radiological and biological behavior (increased hormonal
activity and associated clinical signs of hormonal excess). A thor-
ough pre- and perioperative workup is therefore essential in these
patients (45).
The use of MIS in para-vertebrally located neuroblastoma
has not been reported in large series. These tumors are usually
complex in their anatomical constellation, which is commonly
reflected by their risk stratification using image-defined risk fac-
tors (46). Therefore, they are the primary domain of open surgical
approaches.
RENAL TUMORS
Complete surgical resection is one of the strongest predictors for
outcome in Wilms tumor surgery. Together with the complete
removal of all neoplastic compounds, a sufficient lymph node
sampling is a main goal of surgical treatment in affected children
(47, 48). Laparoscopy is increasingly used for tumor nephrectomy
in nephroblastoma patients (49, 50), however, a systematical analy-
sis from a multicenter trial has been lacking for a long time. The
SIOP Renal Tumor Study Group (RTSG) has recently presented
the first according assessment, which demonstrated a compara-
ble surgical and oncological outcome as in open surgery (51).
However, operating surgeons had above-average experiences with
Wilms tumor surgery in that study. The insufficient discipline of
lymph node sampling was one major aspect of concern to the
investigators. Another important issue is the tumor localization
within the organ. Often small and polar tumors are described as
being resected laparoscopically. However, such lesions are possibly
susceptible for nephron-sparing surgery (NSS). The SIOP RTSG
Surgical Panel therefore formulated the recommendation that MIS
and NSS should not be regarded as competing approaches: if a
tumor can be resected using NSS then this is the preferred method
of choice. The according guidelines are formulated within the
treatment protocol. If a decision for tumor nephrectomy has been
established, then the surgeon might choose MIS as approach (52).
The principles of Wilms tumor surgery remain valid just as in open
surgery.
A technical problem possibly arises because of the tumor size.
Large specimens might be difficult to handle intra-abdominally
with a substantial risk of tumor rupture. However, this has to be
avoided since it is associated with a local up-staging and subse-
quent need for irradiation. The ipsilateral vertebral border seems
to represent a limitation in that regard.
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OVARIAN TUMORS
Complete resection is mandatory for malignant pediatric ovarian
tumors. Diagnosis of ovarian tumors in girls is based on clinical
features (age and hormonal status), imaging, and tumor marker
levels. In the case of benign tumors, preservation of healthy ovar-
ian tissue is crucial. When the lesion is malignant, laparoscopy
has a defined role for establishing an exact diagnosis and for
staging. However, MIS should only be cautiously applied for
resection of malignant pediatric ovarian tumors since laparotomy
via a supra-pubic approach has relevant advantages in ensur-
ing a safe treatment of the lesion by avoiding any risk of tumor
spillage (53, 54).
PANCREATIC TUMORS
Tumors of the pancreas are rare in children. In case of difficul-
ties to establish a diagnosis, MIS might be considered for tumor
biopsy. However, a possible negative impact of MIS through tumor
spillage during biopsy of highly malignant lesions (blastoma, car-
cinoma) has to be strongly taken into consideration. Accordingly,
reports on laparoscopy for pancreatic masses almost exclusively
exist for pseudopapillary tumors (55–57). Despite its challenging
but well-executable technical aspects, there exist relevant concerns
with MIS for pseudopapillary tumors of the pancreas in children
because of tumor recurrence after intraoperative cell spillage (58).
CONCLUSION
Minimally invasive surgery is increasingly being used as surgical
approach in children with solid tumors. Indications and decision-
making processes are still largely varying. Furthermore, there
is a lack of surgical guidelines regarding MIS for the different
tumors within current treatment trials. Therefore, systematical
assessments are necessary to define standardized proceedings.
Retrospective studies should be used at this stage in order to
obtain background information through which investigators will
be enabled to initiate prospective analyses in the future. The pro-
tocols of the various multicenter trial groups around the world
are probably the most promising platforms for integrating such
prospective studies in a comprehensive data acquisition and inter-
pretation. The surgical panels of the various study groups should
make it their goal to formulate guidelines for MIS in pediatric
solid tumors within these protocols. Until such information is
available, MIS for tumors in children should be used with a care-
ful patient selection after thorough decision-making processes. An
exceptional expertise in MIS and surgical oncology is essential for
operating surgeons and treating centers in order to obtain accept-
able treatment outcomes. MIS in pediatric tumor patients has to
be executed within the established treatment regimens formulated
by multicenter trial groups. The regular and defined integration
of MIS within future treatment protocols is only justified if onco-
logical and surgical results are at least on the same level as those
obtained through open surgical procedures.
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